| A randomized trial of factor VIII and neutralizing antibodies in hemophilia A F Peyvandi, PM Mannucci, I Garagiola, A El-Beshlawy, M Elalfy, ... New England Journal of Medicine 374 (21), 2054-2064, 2016 | 513 | 2016 |
| Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A J Astermark, J Oldenburg, J Carlson, A Pavlova, K Kavakli, E Berntorp, ... Blood 108 (12), 3739-3745, 2006 | 285 | 2006 |
| Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors C Leissinger, A Gringeri, B Antmen, E Berntorp, C Biasoli, S Carpenter, ... New England Journal of Medicine 365 (18), 1684-1692, 2011 | 262 | 2011 |
| Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A A Tiede, B Brand, R Fischer, K Kavakli, SR Lentz, T Matsushita, C Rea, ... Journal of thrombosis and haemostasis 11 (4), 670-678, 2013 | 189 | 2013 |
| Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors K Kavakli, M Makris, B Zulfikar, E Erhardtsen, ZS Abrams, G Kenet Thrombosis and haemostasis 95 (04), 600-605, 2006 | 162 | 2006 |
| Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results AD Shapiro, P Angchaisuksiri, J Astermark, G Benson, G Castaman, ... Blood, The Journal of the American Society of Hematology 134 (22), 1973-1982, 2019 | 145 | 2019 |
| Iliopsoas haemorrhage in patients with haemophilia: results from one centre C Balkan, K Kavakli, D Karapinar Haemophilia 11 (5), 463-467, 2005 | 129 | 2005 |
| Endocrine Complications in Patients with β‐thalassemia Major Y Aydinok, S Darcan, A Polat, K Kavakli, G Nişli, M Çoker, M Kantar, ... Journal of tropical pediatrics 48 (1), 50-54, 2002 | 118 | 2002 |
| Prophylaxis vs. on‐demand treatment with BAY 81‐8973, a full‐length plasma protein‐free recombinant factor VIII product: results from a randomized trial (LEOPOLD II) K Kavakli, R Yang, L Rusen, H Beckmann, D Tseneklidou‐Stoeter, ... Journal of Thrombosis and Haemostasis 13 (3), 360-369, 2015 | 95 | 2015 |
| Intracranial haemorrhage in children and adolescents with severe haemophilia A or B–the impact of prophylactic treatment NG Andersson, G Auerswald, C Barnes, M Carcao, AL Dunn, ... British journal of haematology 179 (2), 298-307, 2017 | 82 | 2017 |
| Long‐term evaluation of radioisotope synovectomy with Yttrium 90 for chronic synovitis in Turkish haemophiliacs: Izmir experience K Kavakli, S Aydoğdu, SB Omay, Y DUMAN, M Taner, K Capacı, A Memiş, ... Haemophilia 12 (1), 28-35, 2006 | 80 | 2006 |
| The elevated markers of hypercoagulability in children with Henoch–Schönlein purpura D Yilmaz, K Kavakli, N Ozkayin Pediatric hematology and oncology 22 (1), 41-48, 2005 | 74 | 2005 |
| Health‐related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti‐inhibitor complex concentrate: results from the Pro‐FEIBA study A Gringeri, C Leissinger, PA Cortesi, H Jo, F Fusco, S Riva, B Antmen, ... Haemophilia 19 (5), 736-743, 2013 | 73 | 2013 |
| Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies P Monagle, AWA Lensing, K Thelen, I Martinelli, C Male, A Santamaría, ... The Lancet Haematology 6 (10), e500-e509, 2019 | 63 | 2019 |
| Safety and efficacy of a glycoPEGylated rFVIII (turoctocog alpha pegol, N8-GP) in paediatric patients with severe haemophilia A S Meunier, J Alamelu, S Ehrenforth, H Hanabusa, FA Karim, K Kavakli, ... Thrombosis and haemostasis 117 (09), 1705-1713, 2017 | 63 | 2017 |
| Prospective evaluation of whole genome microRNA expression profiling in childhood acute lymphoblastic leukemia M Duyu, B Durmaz, C Gunduz, C Vergin, D Yilmaz Karapinar, S Aksoylar, ... BioMed research international 2014, 2014 | 63 | 2014 |
| Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid G Serdaroglu, S Tütüncüoğlu, K Kavakli, H Tekgiil Journal of child neurology 17 (1), 41-43, 2002 | 63 | 2002 |
| Sequential use of deferiprone and desferrioxamine in primary school children with thalassaemia major in Turkey Y Aydinok, G Nisli, K Kavakli, C Coker, M Kantar, N Cetingül Acta Haematologica 102 (1), 17-21, 1999 | 63 | 1999 |
| A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A H Eichler, P Angchaisuksiri, K Kavakli, P Knoebl, J Windyga, ... Journal of thrombosis and Haemostasis 16 (11), 2184-2195, 2018 | 61 | 2018 |
| Safer circumcision in patients with haemophilia: the use of fibrin glue for local haemostasis A Avanoglu, A Celik, I Ulman, C Özcan, K Kavakli, G Nişli, A Gökdemir BJU international 83 (1), 91-94, 1999 | 60 | 1999 |
